Artificial Intelligence in Mammography Screening in Norway
Recruiting
N/A
Interventional Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 50 – 69
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 150,000 (estimated)
- Sponsor
- Norwegian Institute of Public Health · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this randomized controlled trial is to compare the number of breast cancers detected among women who had their screening mammograms interpreted by artificial intelligence (AI) in combination with one or two breast radiologists to the number of breast cancers detected after standard independent double reading in BreastScreen Norway. The aims of the study is to prove that screening in…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women attending the population-based mammography screening program BreastScreen Norway providing a signed, informed consent
Exclusion Criteria:
* Women attending the population-based mammography screening program BreastScreen Norway not providing a signed, informed consent
Contacts